Mostrar registro simples

dc.contributor.authorCotrim, Helma Pinchemelpt_BR
dc.contributor.authorOliveira, Claudia Pinto Marques Souza dept_BR
dc.contributor.authorCoelho, Henrique Sérgio Moraespt_BR
dc.contributor.authorÁlvares-da-Silva, Mário Reispt_BR
dc.contributor.authorNabuco, Leticia Cancellapt_BR
dc.contributor.authorParise, Edison Robertopt_BR
dc.contributor.authorIvantes, Cláudia Alexandra Pontespt_BR
dc.contributor.authorMartinelli, Ana de Lourdes Candolopt_BR
dc.contributor.authorGalizzi Filho, Joãopt_BR
dc.contributor.authorCarrilho, Flair Josépt_BR
dc.contributor.authorSociedade Brasileira de Hepatologia. Members of the NAFLD-HCC Surveypt_BR
dc.date.accessioned2018-11-01T02:49:52Zpt_BR
dc.date.issued2016pt_BR
dc.identifier.issn1980-5322pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/184314pt_BR
dc.description.abstractOBJECTIVE: The majority of cases of hepatocellular carcinoma have been reported in individuals with cirrhosis due to chronic viral hepatitis and alcoholism, but recently, the prevalence has become increasingly related to nonalcoholic steatohepatitis around the world. The study aimed to evaluate the clinical and histophatological characteristics of hepatocellular carcinoma in Brazilians’ patients with nonalcoholic steatohepatitis at the present time. METHODS: Members of the Brazilian Society of Hepatology were invited to complete a survey regarding patients with hepatocellular carcinoma related to nonalcoholic steatohepatitis. Patients with a history of alcohol intake (420 g/day) and other liver diseases were excluded. Hepatocellular carcinoma diagnosis was performed by liver biopsy or imaging methods according to the American Association for the Study of Liver Diseases’ 2011 guidelines. RESULTS: The survey included 110 patients with a diagnosis of hepatocellular carcinoma and nonalcoholic fatty liver disease from nine hepatology units in six Brazilian states (Bahia, Minas Gerais, Rio de Janeiro, Sa˜o Paulo, Parana´ and Rio Grande do Sul). The mean age was 67±11 years old, and 65.5% were male. Obesity was observed in 52.7% of the cases; diabetes, in 73.6%; dyslipidemia, in 41.0%; arterial hypertension, in 60%; and metabolic syndrome, in 57.2%. Steatohepatitis without fibrosis was observed in 3.8% of cases; steatohepatitis with fibrosis (grades 1-3), in 27%; and cirrhosis, in 61.5%. Histological diagnosis of hepatocellular carcinoma was performed in 47.2% of the patients, with hepatocellular carcinoma without cirrhosis accounting for 7.7%. In total, 58 patients with cirrhosis had their diagnosis by ultrasound confirmed by computed tomography or magnetic resonance imaging. Of these, 55% had 1 nodule; 17%, 2 nodules; and 28%, X3 nodules. CONCLUSIONS: Nonalcoholic steatohepatitis is a relevant risk factor associated with hepatocellular carcinoma in patients with and without cirrhosis in Brazil. In this survey, hepatocellular carcinoma was observed in elevated numbers of patients with steatohepatitis without cirrhosis.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofClinics (São Paulo). São Paulo. Vol. 71, n. 5 (May 2016), p. 281-284pt_BR
dc.rightsOpen Accessen
dc.subjectCarcinoma hepatocelularpt_BR
dc.subjectNon-alcoholic fatty liver diseaseen
dc.subjectNeoplasias hepáticaspt_BR
dc.subjectNonalcoholic steatohepatitisen
dc.subjectHepatocellular carcinomaen
dc.subjectCirrose hepáticapt_BR
dc.subjectFatty liveren
dc.subjectComplicações do diabetespt_BR
dc.subjectFatores de riscopt_BR
dc.subjectHepatopatia gordurosa não alcoólicapt_BR
dc.subjectBrasilpt_BR
dc.titleNonalcoholic steatohepatitis and hepatocellular carcinoma : Brazilian surveypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001078735pt_BR
dc.type.originNacionalpt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples